JBIO vs WYNN · $868.2M cap vs P/E 29, rev $7.14B
Jade Biosciences, Inc. (JBIO) versus Wynn Resorts Limited (WYNN) — a side-by-side from cached financials, not a winner call.
Jade Biosciences, Inc. (JBIO) is a biotechnology company listed on US.
Wynn Resorts Limited (WYNN) is a resorts & casinos company listed on NASDAQ.
JBIO does not have a complete income-statement cache yet.
Latest reported WYNN revenue for 2025-12-31 was $7.14B. Net income was $327.3M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
JBIO currently screens at market cap $868.2M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
Not investment advice. Open the JBIO and WYNN stock pages for the full models.
Not investment advice.